What's new

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised

Mar 17, 2025 - 17:11
 0
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Skilarence, dimethyl f...

Next Article

Expo West: Plant Press Pushes Forward, Humm Flexes Formats

Related Posts

Demonstration of efficacy for veterinary medicinal products containing antimicrobial substances - Scientific guideline

Demonstration of efficacy for veterinary medicinal prod...

Feb 21, 2025  0

Human medicines European public assessment report (EPAR): Apretude, cabotegravir, Date of authorisation: 15/09/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 1 April 2025, 09:00 (CEST) to 2 April 2025, 15:50 (CEST)

European Medicines Agency (EMA) Patients' and Consumers...

Mar 3, 2025  0